Intravenous to Oral Conversion for Antimicrobials - Northern Health All patients initiated on IV antimicrobials will be assessed for conversion to oral antibiotics Oral antimicrobials will be used preferentially whenever appropriate for the clinical circumstances of the patient
A Resource To Help With Changing From IV To PO Antibiotics Changing from IV to PO antibiotics is an important antimicrobial stewardship intervention In this article factors to consider when transitioning from an IV antibiotic to a PO antibiotic are discussed and relevant resources are identified
SHC “Tips” for Discharging Patients on Parenteral Antibiotics Clinicians should routinely assess for the need for antibiotic therapy and for opportunities to transition patients to oral antimicrobials In many instances, oral therapy can circumvent the need for OPAT
IV to Oral Antibiotic Switch Therapy (IVOST) Guideline (Adults) Most infections require ≤7 days total (IV + PO) of antibiotics Record the intended duration in the notes, and add a stop date to HEPMA If required, advice is available from Infectious Diseases, Medical Microbiology or Pharmacy
Practice of switch from intravenous to oral antibiotics - PMC The aim of the study was to evaluate the practice of switching from IV to PO antibiotics based on predefined eligibility criteria and its impact on clinical outcomes as the duration of IV antibiotic therapy and LOS, and to assess the correlation between the type of conversion and antibiotic classes
Pharmacist Driven Intravenous (IV) to Oral (PO) Conversion Protocol Pharmacist Driven Intravenous (IV) to Oral (PO) Conversion Protocol Procedure: The following medications, due to their unique properties of having the intravenous and oral routes of administration being therapeutically equivalent and interchangeable, will be included in the protocol:
Pharmacist Driven Intravenous (IV) to Oral (PO) Conversion Protocol Pharmacist Driven Protocol: Upon meeting the established criteria for transitioning to oral therapy (Section C) the pharmacist will determine if it is clinically appropriate to perform a sequential IV to PO therapy interchange for the antibiotics outlined in Table 1 only